Domainex, a UK-based drug discovery company, has raised £1.5m ($2m) to accelerate research from investors including University College London Business (UCLB).

The firm had a first close in December, which was also joined in participation by venture firm Bury Fitzwilliam-Lay and Partners and led by Longbow Capital. A second close is planned in April for the Cambridge, UK-based firm with Longbow Capital leading the round.

Longbow previously led a £718,000 round in Domainex in 2008, which was joined by YFM…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?